Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors

INTRODUCTION: Cell-based immunotherapy is categorized as a regenerative therapy under the Regenerative Medicine Safety Act in Japan. Natural killer (NK) cell-based immunotherapy is considered a promising strategy for treating cancer, including glioblastoma (GBM). We previously reported an expansion...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakazawa, Tsutomu, Morimoto, Takayuki, Maeoka, Ryosuke, Matsuda, Ryosuke, Nakamura, Mitsutoshi, Nishimura, Fumihiko, Yamada, Shuichi, Nakagawa, Ichiro, Park, Young-Soo, Nakase, Hiroyuki, Tsujimura, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309574/
https://www.ncbi.nlm.nih.gov/pubmed/35919498
http://dx.doi.org/10.1016/j.reth.2022.07.001

Ejemplares similares

Ejemplares similares